Taking medical innovation beyond the lab.

SCIENCE · TECHNOLOGY · COMMERCIALIZATION

Supporting the commercialization of emerging healthcare technologies at Imperial College London.

WORK

Commercialization strategies across a portfolio of emerging medical technologies.

Assessed intellectual property, market opportunity and potential routes to market.

PROJECTS

AI for Alzheimer's disease, AI for cardiovascular disease, AI for sarcopenia, AI for metabolomics, surgical simulation and novel therapeutics.

Previous

Early-stage Venture Capital Fund, London
Next

Private Family Office, London